Medication 7-965 - Xopenex (Levalbuterol)
Polk, Hickory, Cedar, & St Clair EMS Protocols
Scope of Practice:
- Advanced Emergency Medical Technician
- Registered Nurse
- Paramedic
- Community Paramedic
Route(s):
Pharmacodynamics (class and mechanism of action):
- β2 (Beta-2) Agonist (β2 Beta-2 receptor agonist with some β1 Beta-1 activity).
Pharmacokinetics:
- Half-life: 3.25-4 hours.
- Onset time: 5-15 minutes.
- Peak action time: 1 hour.
- Duration of action: 3-4 hours.
Peak | 21 | 42 | 63 | 84 | 105 | 126 | 147 | 168 | 189 | 210 | 231 | minutes |
Duration | 21 | 42 | 63 | 84 | 105 | 126 | 147 | 168 | 189 | 210 | 231 | minutes |
Dosing:
- Refer to specific protocol(s) below for dose(s).
Indications:
Contraindications:
- Hypersensitivity to Levalbuterol or Racemic Albuterol.
Pregnancy Risk Factor:
- Category C
- Risk not ruled out: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. FDA requires a relatively large amount of high-quality data on a pharmaceutical for it to be defined as Pregnancy Category A. As a result of this, many drugs that would be considered Pregnancy Category A in other countries are allocated to Category C by the FDA.
Potential Incompatibilities:
Precautions and Adverse Effects:
- Use caution with arrhythmias, Hypertension, paradoxical Bronchospasm.
- May cause rhinitis, headache, tremor, sinusitis, Tachycardia, nervousness, edema, Hyperglycemia, and/or hypokalemia.
Antidote:
Controlled Substance Information:
- Not a scheduled drug
- The DEA and FDA have not identified this drug with a schedule classification.
- DEA number: NA.
- Narcotic: No.
- Street names: NA.
Citations:
- Protocol 9-010 - References
- Comerford & Labus, 2010.
- Donohue, et al., 2008.
- Lam & Chen, 2003.
- Nowak, et al., 2006.
- Tripp, et al., 2008.
- Truitt, Witko, & Halpern, 2003.
Change Log:
Date | Link topreviousversion | Description of change |
---|
05/18/20 | pdf | Added content (without substantive modification) from old Protocol 7-610 - Xopenex. |
06/11/21 | pdf | Moved to emsprotocols.online |
11/30/21 | | Updated link to Albuterol. |
12/01/21 | | Changed number from 7-610 to 7-965. |
03/21/23 | pdf | Added CP. |
CMH PHS Mission: "Provide safe, exceptional, and compassionate care to our communities with an emphasis on highly trained and empowered staff." |
|